March 17, 2006 (Atlanta) — Tens of thousands of lives could be saved if all eligible patients hospitalized with heart failure were discharged on beta-blockers, according to researchers who found that ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The use of ...

A combination of silybin and carvedilol is more effective than either drug alone for treating liver fibrosis, found a new study published in Targetome. Liver fibrosis is a chronic and multifactorial ...

Aims Various beta-blockers with distinct pharmacological profiles are approved in heart failure, yet they remain underused and underdosed. Although potentially of major public health importance, ...